- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05294198
Beetroot Extract and Its Influence on Cardiovascular and Autonomic Recovery From the Effort in Healthy Males
March 14, 2022 updated by: Cicero Jonas R Benjamim, University of Pernambuco
There is no evidence that beetroot extract (Beta vulgaris L.) is advantageous for the recovery of cardiovascular parameters and the autonomic nervous system (ANS) after submaximal aerobic exercise.
The objective of this study is to evaluate the effect of beetroot extract supplementation on the recovery of cardiorespiratory and autonomic parameters after a submaximal aerobic exercise session.
Healthy male adults will perform a cross-over, randomized, double-blind, and placebo-controlled trial.
Beetroot extract (600mg) or placebo (600mg) will be ingested 90 minutes before evaluation in randomized days.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), mean arterial pressure (MAP), heart rate (HR), and HR variability (HRV) indexes will be recorded at Rest and during 60 minutes of recovery from exercise.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pernambuco
-
Petrolina, Pernambuco, Brazil, 56328-900
- University of Pernambuco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy males;
- Physically active according to International Physical Activity Questionnaire (IPAQ);
- 18 to 30 old years.
Exclusion Criteria:
- Body mass index BMI <18.5kg/m² and >29.9kg/m²;
- Smokers;
- Subjects undergoing pharmacotherapies;
- Musculoskeletal, metabolic, renal diseases;
- Root mean squared standard deviation of R-R intervals <15 milliseconds.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Beet protocol
Beta vulgaris L. extract (600mg)
|
Beetroot extract capsule
|
|
Placebo Comparator: Placebo protocol
Starch (600mg)
|
Beetroot extract capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Heart rate variability values (milliseconds)
Time Frame: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Systolic and diastolic blood pressure values (mmHg)
Time Frame: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
Heart rate values (beats per minute)
Time Frame: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cicero Benjamim, nutricionist, University of Pernambuco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2021
Primary Completion (Actual)
November 12, 2021
Study Completion (Actual)
November 12, 2021
Study Registration Dates
First Submitted
March 4, 2022
First Submitted That Met QC Criteria
March 14, 2022
First Posted (Actual)
March 24, 2022
Study Record Updates
Last Update Posted (Actual)
March 24, 2022
Last Update Submitted That Met QC Criteria
March 14, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- PX086
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Males
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHealthy MalesUnited States
-
Maastricht University Medical CenterRecruiting
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
The Hospital for Sick ChildrenCompleted
-
Mohamad KaramCompleted
-
Faculdade de Motricidade HumanaRecruitingHealthy Males | MenPortugal
-
University of TorontoCompletedHealthy Adult MalesCanada
-
University of British ColumbiaAjinomoto Co., Inc.Completed
-
Altesa Biosciences, Inc.CompletedHealthy MalesUnited Kingdom
Clinical Trials on Beetroot extract
-
University of PernambucoCompletedCardiovascular Diseases | PreventionBrazil
-
National Institute of Cardiology, Laranjeiras,...RecruitingArterial Hypertension | Resistant Hypertension | Microvascular Function | Nitrate SupplementationBrazil
-
Oxford Brookes UniversityNot yet recruitingHypertension | Type 2 Diabetes Mellitus | Autonomic Nervous System DiseasesUnited Kingdom
-
NIHR Exeter Clinical Research FacilityTorbay and South Devon NHS Foundation TrustCompleted
-
University of CoimbraRecruitingDiabete Mellitus | Small Vessel Cerebrovascular DiseasePortugal
-
University Hospital, GhentUniversity GhentTerminated
-
Bangor UniversityCompleted
-
Western Norway University of Applied SciencesCompleted
-
Universidad Francisco de VitoriaUniversity of Alcala; University of SevilleCompleted